Publications by authors named "May-Ying Hsu"
Article Synopsis
- Since 2012, several immune checkpoint inhibitors have been approved for cancer treatment in Taiwan, but they aren't covered by national health insurance due to high costs and insufficient effectiveness data.
- This study analyzed the clinical use of these drugs, focusing on their effectiveness, types of prescriptions, and side effects in patients treated at a major hospital over a two-year period.
- Results showed that non-small cell lung cancer was the most common indication, with overall survival and progression-free survival rates that were consistent with existing clinical trials, although specific patient subgroups experienced lower survival outcomes.
Objective: To report a case of ofloxacin/levofloxacin-induced rhabdomyolysis and to compare other reported cases from the literature.
Case Summary: A 19-year-old male patient developed ofloxacin/levofloxacin-induced rhabdomyolysis during admission for periorbital cellulitis. Symptoms of myalgia, weakness, and swelling of the arms developed after 3 days of treatment with ofloxacin 800 mg/day.
A 43-year-old woman with liver cirrhosis and hepatocellular carcinoma was admitted for the chief problem of ascites. Laboratory data revealed a leukocyte count of 3.8 x 10(9)/L on the second day of admission.
View Article and Find Full Text PDF